EDARBYCLOR-1 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

EDARBYCLOR-1
US Patents

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

pharmacompass-1-m-2026-01-12

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

Contact Supplier

Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

Contact Supplier

pharmacompass-2-2026-02-09

EDARBYCLOR-1

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

42 API Suppliers, 23 USDMF, 7 CEP/COS, 9 EU WC, 15 KDMF, 12 NDC API, 16 Listed Suppliers, $ API Reference Price

42 API Suppliers
23 USDMF
7 CEP/COS
9 EU WC
15 KDMF
12 NDC API
16 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

206 FDF Dossiers, 121 FDA Orange Book, 59 Europe, 8 Canada, 2 Australia, 5 South Africa, 11 Listed Dossiers

206 FDF Dossiers
121 FDA Orange Book
59 Europe
8 Canada
2 Australia
5 South Africa
11 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG;25MG, TABLET;ORAL - 50MG;25MG, TABLET;ORAL - 15MG, TABLET;ORAL - 25MG, TABLET;ORAL - EQ 40MG MEDOXOMIL;12.5MG, TABLET;ORAL - EQ 40MG MEDOXOMIL;25MG, TABLET;ORAL - 25MG, TABLET;ORAL - 50MG

TABLET;ORAL - 100MG;25MG
TABLET;ORAL - 50MG;25MG
TABLET;ORAL - 15MG
TABLET;ORAL - 25MG
TABLET;ORAL - EQ 40MG MEDOXOMIL;12.5MG
TABLET;ORAL - EQ 40MG MEDOXOMIL;25MG
TABLET;ORAL - 25MG
TABLET;ORAL - 50MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 17 SPI Pharma, 4 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 1 Pfanstiehl, 1 Kirsch Pharma, 1 ACG Worldwide, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 17 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 7 Gangwal Chemicals, 4 Ideal Cures, 5 Ingredion Pharma Solutions, 11 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 2 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 22 Roquette, 8 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 5 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 43 Coating Systems & Additives, 31 Disintegrants & Superdisintegrants, 28 Direct Compression, 23 Lubricants & Glidants, 23 Granulation, 19 Controlled & Modified Release, 18 Chewable & Orodispersible Aids, 18 Taste Masking, 17 Thickeners and Stabilizers, 14 Co-Processed Excipients, 9 Film Formers & Plasticizers, 9 Solubilizers, 6 Parenteral, 5 Empty Capsules, 5 API Stability Enhancers, 5 Emulsifying Agents, 4 Vegetarian Capsules, 3 Rheology Modifiers, 2 Coloring Agents, 2 Topical, 1 Surfactant & Foaming Agents

61 Fillers, Diluents & Binders
43 Coating Systems & Additives
31 Disintegrants & Superdisintegrants
28 Direct Compression
23 Lubricants & Glidants
23 Granulation
19 Controlled & Modified Release
18 Chewable & Orodispersible Aids
18 Taste Masking
17 Thickeners and Stabilizers
14 Co-Processed Excipients
9 Film Formers & Plasticizers
9 Solubilizers
6 Parenteral
5 Empty Capsules
5 API Stability Enhancers
5 Emulsifying Agents
4 Vegetarian Capsules
3 Rheology Modifiers
2 Coloring Agents
2 Topical
1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 35 News #PharmaBuzz

3 Data Compilation #PharmaFlow
35 News #PharmaBuzz

GLOBAL SALES INFORMATION

28 US Medicaid Prescriptions, 43 Regulatory FDF Prices

28 US Medicaid Prescriptions
43 Regulatory FDF Prices

MARKET PLACE

20 APIs

20 APIs

PATENTS & EXCLUSIVITIES

6 US Patents, 12 Health Canada Patents

6 US Patents
12 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 5 Others

2 EDQM
5 Others

ANALYTICAL

1 BioAnalytical Methods, 4 Analytical Methods

1 BioAnalytical Methods
4 Analytical Methods

$ API Ref.Price (USD/KG) : 184 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 6AZURITY

filter Patent Number Reset all filters

6 All

01 29066936

02 29169238

03 29387249

API Patent Reset all filters

6 All

01 6Blank

filter FDF Patent Reset all filters

6 All

01 4Y

02 2Blank

filter Expiration Date Reset all filters

6 All

01 22028-03-26

02 22030-02-04

03 22031-07-01

Product Main Page

01

AZURITY

AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE

euroPLX 90 Lisbon

Not Confirmed

AZURITY

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-07-01

AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE

US Patent Number : 9387249

Drug Substance Claim :

Drug Product Claim :

Application Number : 202331

Patent Use Code : U-3

Delist Requested :

Patent Use Description : TREATMENT OF HYPERTENS...

Patent Expiration Date : 2031-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

AZURITY

AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE

euroPLX 90 Lisbon

Not Confirmed

AZURITY

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-07-01

AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE

US Patent Number : 9387249

Drug Substance Claim :

Drug Product Claim :

Application Number : 202331

Patent Use Code : U-3

Delist Requested :

Patent Use Description : TREATMENT OF HYPERTENS...

Patent Expiration Date : 2031-07-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

AZURITY

AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE

euroPLX 90 Lisbon

Not Confirmed

AZURITY

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-02-04

AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE

US Patent Number : 9169238

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202331

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-02-04

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

AZURITY

AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE

euroPLX 90 Lisbon

Not Confirmed

AZURITY

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-02-04

AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE

US Patent Number : 9169238

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202331

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-02-04

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

AZURITY

AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE

euroPLX 90 Lisbon

Not Confirmed

AZURITY

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-03-26

AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE

US Patent Number : 9066936

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202331

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-03-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

AZURITY

AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE

euroPLX 90 Lisbon

Not Confirmed

AZURITY

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-03-26

AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE

US Patent Number : 9066936

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202331

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-03-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.